Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-25 @ 7:23 PM
NCT ID: NCT00411632
Description: None
Frequency Threshold: 5
Time Frame: January 1, 2007 to November 24, 2009 Participants were assessed for response until progression and for survival up to 3 years following completion of study treatment.
Study: NCT00411632
Study Brief: BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Erlotinib + Bexatrtene Bexarotene 400 mg/m\^2 by mouth daily x 28 Days. Erlotinib 150 mg by mouth daily x 28 Days. Bexarotene: 400 mg/m\^2 by mouth daily x 28 Days Erlotinib: 150 mg by mouth daily x 28 Days 1 None 8 37 13 37 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hypertriglyceridema SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Lipase increased SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Fatigue SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
INR SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hypothyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders CTCAE (3.0) View
Hypertriglceridemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Acne SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View